FDA Approves New Treatment for Ulcerative Colitis

WEDNESDAY, May 30, 2018 -- U.S. Food and Drug Administration approval of Xeljanz (tofacitinib) has been expanded to include adults with active moderate-to-severe ulcerative colitis, the agency said Wednesday. Xeljanz was first approved in 2012 for...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news